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108 Session: Regenerative MedicineDetermination of glycosaminoglycan (GAG) content: The synthesised GAG was
determined by binding to DMB dye and the total amount of GAG was normalised to
the amount of DNA by a PicoGreen dsDNA assay.
mRNA expression assay: Expressions of type I, II, X collagen, SOX-9, and aggrecan
were analysed by real-time PCR. Expression of GAPDH was taken as an internal
control.
Histologic and immunohistochemical examination: Pellets from each time point
were stained with H&E and safranin-O for proteoglycan detection. The expression
of type II collagen was detected by immunohistochemical (IHC) staining.
Results: Co-culture of human SDSCs and chondrocytes exhibited significantly
higher GAG synthesis and type II collagen content. Furthermore, expression of
type X collagen, a marker of MSC hypertrophy, was significantly lower in the co-
culture pellets. The co-culture groups exhibited up-regulation of type II collagen
and Sox-9 at seven days, and type I collagen, type X collagen, and aggrecan at
14 days. Safranin-O staining and IHC staining for type II collagen showed that chon-
drogenic differentiation of the co-culture group were higher than those of the
chondrocytes or SDSCs single culture groups.
Discussion: Our results demonstrated that mixed co-culture of SDSCs and chondro-
cytes reduced cellular hypertrophy and enhance in vitro chondrogenesis when
compared to the culture of chondrocytes or SDSCs alone.
http://dx.doi.org/10.1016/j.jot.2016.06.120414
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Introduction: Platelet-rich plasma (PRP) has been advocated as one treatment
strategy for cartilage tissue regeneration. To date, several different platelet-
rich formulations have been made available, but a deep knowledge of their compo-
sition and mechanism of action in a specific clinical use is needed. There are many
variations in PRP formulations, with both platelet and leukocyte concentrations
having been identified as major constituents affecting the inflammatory responses
after PRP injection. The aim of this study was to investigate the effect of leuko-
cyte depletion in PRP on the proliferation and chondrogenesis of synovium-derived
MSCs (SD-MSCs) and chondrocytes.
Methods: Preparation of PRP formulations: From donated human fresh blood, we
prepared three formulations of PRP: (1) platelet-poor plasma (PPP), (2) PRP with
very few leukocytes (P-PRP), and (3) PRP with high concentrations of both plate-
lets and leukocytes (L-PRP). PPP is the upper layer of plasma after centrifuging
10cc whole blood at 2400rpm for 10 minutes. After 2nd centrifuging at 3600rpm
for 15 minutes, P-PRP is the lower layer of plasma without buffy coat. L-PRP is
the lower layer of plasma with buffy coat.
Cell culture and in-vitro expansion: SD-MSCs and chondrocytes were obtained from
patients undergoing total knee arthroplasty. The primary cells were expanded in
DMEM with the three formulations. The cell proliferation was measured using
the MTT assay.
Chondrogenesis: Chondrogenic differentiation of SD-MSCs and expanded chondro-
cytes were induced using a high-density pellet culture system. Aliquots of 5105
cells were centrifuged at 500g for 5 minutes, which were subsequently cultured
for three weeks. The pellets of SD-MSCs and chondrocytes were cultured in chem-
ically defined chondrogenic medium with 10 ng/ml of TGF-b1 and/or 100 ng/ml of
BMP-2.
Real-time PCR: Total RNA from SD-MSCs and chondrocytes were extracted by using
the RNeasy mini kit (Qiagen). Expressions of type II collagen, type X collagen,
Aggrecan, and Sox9 were analysed by RT-PCR. Expression of GAPDH was taken as
the internal control.
Histological and immunohistochemical examination: Pellets were stained with
Safranin-O for proteoglycan detection. The expression of type II collagen was
detected by IHC staining and was observed under microscopy.
Results: Leukocyte depletion also lowered the count of platelets. L-PRP
showed more proliferative effect on SD-MSCs and chondrocytes than P-PRP.
RT-PCR revealed higher cartilage gene expression in TGF-b1 induced chondro-
genesis of SD-MSCs and chondrocytes with P-PRP. However, there was a nega-
tive effect of both formulations in TGF-b1/BMP induced chondrogenesis. In
TGF-b1 and/or BMP induced chondrogenesis, the SD-MSC pellet with P-PRP
showed more proteoglycan production than those with L-PRP. Type II collagen
synthesis in the chondrocyte pellets with P-PRP was greater than the pellets
with L-PRP. However, type II collagen synthesis in SD-MSCs pellets was not
detected.
Discussion: Although leukocyte depletion in PRP showed a negative effect on
proliferation of SD-MSCs and chondrocytes and a positive effect on the mRNA
expression of the chondrogenic differentiation marker genes, it could not
change the negative effects of PRP on chondrogenic differentiation of SD-
MSCs.
http://dx.doi.org/10.1016/j.jot.2016.06.121465
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Introduction: Mesenchymal stem cells (MSCs) are believed to be immune-privi-
leged due to lack of antigen-presenting-cell related markers; however, evidence
suggests that MSCs are immunogenic and are attacked by the immune system.
Our research investigates the hypothesis that there are differences between MSC
clones from the same individual in terms of their morphology, proliferation, differ-
entiation, and immune profile. Our goal is to discover immune-privileged stem
cells, which can act as a universal allogenic mesenchymal stem cell donor to facil-
itate bone ingrowth for osteosarcoma patients’ status post tumour excision and
prosthesis implantation.
Subjects and Methods: Serial dilutions of bone-marrow derived (BMMSCs) and ad-
ipose derived mesenchymal stem cells (ADMSCs) from the same animal were car-
ried out in order to isolate single-cell clones. From a single animal we obtained
three clones from BMMSCs and three from ADMSCs. This procedure was repeated
for another two animals. The proliferation rate and cell doubling time of each
clonal culture was measured. The proliferation rate of mixed clonal cultures
was also measured. The tri-differentiation potential of the clonal cultures was
compared and a comparison was also made with the original isolates from bone
marrow and fat. The immune-privileged properties were measured by flow cytom-
etry and immuno-staining for the major histocompatibility complex (MHC) anti-
gens. To measure the immune response a mixed leucocyte reaction was used
but where leucocytes from a different individual were mixed with the clonal
MSC cells.
Results: All isolates were able to differentiate into osteoblasts, chondrocytes, and
adipocytes. All clonal cultures revealed significantly different proliferation rates
and doubling times when compared with each other and with mixed cultures. All
clonal cultures showed different surface marker presentations, which included dif-
ferences in the expression of MHC antigens. One clone isolated from ADMSCs
showed a lack of MHCI and MHCII. Our mixed leucocyte reaction and MHC staining
showed a variety of immune-modulation and this was related to the expression of
the MHC antigens.
Discussion and Conclusion: All clones tri-differentiated and therefore show a
degree of ‘stemness’. MSCs are generally believed not to express MHCII and to
be immune-privileged. However, this study shows that the expression of these
antigens in clones isolated from bone marrow and from fat is variable. A het-
erogeneous result indicates individual differences between MSCs, even from
the same origin. The immune response elicited by MSCs is complicated.
MSCs have been shown to release interleukin 10, which could inhibit the im-
mune response but on the other hand interferon-gamma could enhance MHCII
presentation in some MSCs. Our results confirmed our hypothesis because
clonal cultures isolated from different sources of MSCs in the same animal
show differences in proliferation rate, morphology, and surface marker pre-
sentation. Mesenchymal stem cells are not immunogenic or immune-privi-
leged. Individual differences highlighted through single-cell clonal cultures
may be the key to finding universal immune-privileged MSCs for allogeneic
transplantation.
http://dx.doi.org/10.1016/j.jot.2016.06.122473
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Background: Adipose derived stem cells (ASCs) based therapy is a promising strat-
egy to promote in musculoskeletal repair. Cell differentiation ability, trophic fac-
tor and immunomodulation are considered as possible mechanisms to regenerate
new tissue. However, the cell fate after implantation is required to understand
treatment effects. In this study, we would like to investigate Iron sucrose labeling
as the tool for MSC fate. Cell immunophenotypes, cell viability, cell differentiation
ability after labelling are evaluated. Iron sucrose labelled MSCs were determined
using 3 tesla (3T) MRI in vitro
Materials and methods: Adipose-derived mesenchymal stem cells (ASCs) were iso-
lated from liposuction specimen from subcutaneous tissue. Passage 3rd ASCs were
labelled with iron sucrose by adding in basal culture media (1 mg/ml) and
